Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese pharma ...
Our friends at Paper and Plastick are stepping up to help out one of their bands, Protagonist. Earlier this year the band had $22,000 worth of gear stolen right before entering the studio to record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback